Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/8/2007 First Published: 6/1/2000


1.		Phase III Randomized Study of Whole Brain Radiotherapy With or Without RSR13 in Patients With Brain Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Pharmaceutical / Industry				ALLOS-RSR13RT-009 NCT00005887

Last Modified: 8/1/2007 First Published: 2/21/2003


2.		Phase III Randomized Study of Induction Chemotherapy Followed By Radiotherapy With or Without Efaproxiral in Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				ALLOS-RSR13RT-013ELITE NCT00055887


3.		Standard Whole Brain Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Women With Brain Metastases From Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Pharmaceutical / Industry				ENRICH Study Brain Metastases, Breast Cancer, NCT00083304

Last Modified: 2/15/2007 First Published: 6/1/2000


4.		Phase I/II Study of Efaproxiral and Carmustine in Patients With Progressive or Recurrent High-Grade Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				NABTT-9806 JHOC-NABTT-9806, NCT00005855, NABTT-9806

Last Modified: 9/20/2005 First Published: 3/1/1998


5.		Phase II Study of RSR13 in Patients Receiving Cranial Radiation Therapy for Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				NABTT-9707 ALLOS-RSR13RT-007, JHOC-NABTT-9707, NABTT-9707

Last Modified: 4/20/2007 First Published: 11/1/1999


6.		Phase II Study of RSR-13 in Patients With Primary Breast, Non-Small Cell Lung, Genitourinary, or Gastrointestinal Carcinoma or Melanoma Receiving Standard Cranial Radiotherapy for Brain Metastases (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				UCLA-9711049 ALLOS-RSR13RT-008, NCI-G99-1611

Last Modified: 11/8/2007 First Published: 1/1/2000


7.		Phase II Study of Induction Chemotherapy With Paclitaxel and Carboplatin Followed By Radiotherapy Plus RSR13 in Patients With Locally Advanced Unresectable Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				ALLOS-RSR13RT-010 VU-VCC-THO-9828, NCT00004202

Last Modified: 9/21/2005


8.		Phase IB Study to Evaluate the Safety and Tolerance of Repetitive Daily Intravenous Doses of RSR-13 Administered to Patients Receiving Cranial Radiation Therapy for Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Pharmaceutical / Industry				NABTT-9606 JHOC-NABTT-9606, NCI-T96-0085, NABTT-9606

Select All on One Page